Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

TerminatedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

March 4, 2020

Primary Completion Date

July 11, 2021

Study Completion Date

July 11, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Linagliptin

drug

DRUG

Acarbose

drug

Trial Locations (10)

100074

No.731 Hospital of China Aerospace Science & Industry Corp., Beijing

200000

Shanghai TCM-Integrated Hospital, Shanghai

210008

Nanjing Drum Tower Hospital, Nanjing

210009

Zhongda Hospital Southeast University, Nanjing

215699

Zhangjiagang First People Hospital, Suzhou

223300

Huai'an first people's hospital, Huai'an

257000

Dongying People's Hospital, Dongying

400014

ChongQing The Fourth Hospital, Chongqing

518110

Southern Medical University Shenzhen Hospital, Shenzhen

610081

Affiliated Hospital of Chengdu University, Chengdu

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY